The Kaplan–Meier analysis revealed that the AML patients with high levels of SMPDL3B mRNA had a significantly poorer overall survival in the TCGA and GEPIA groups, respectively (Figures 2A,B). Here, SMPDL3B is linked to acute myeloid leukemia.